Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Mossner

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Annals of Hematology|February 27, 2024
Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic NeoplasmsAlexander Streuer, Johann-Christoph Jann, Tobias Boch, et al.
Oncotarget|November 22, 2017
Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancerElke Burgermeister, Patrick Höde, Johannes Betge, et al.
Journal of Medical Genetics|June 11, 2017
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNAJohann-Christoph Jann, Daniel Nowak, Florian Nolte, et al.
Genes, Chromosomes & Cancer|April 11, 2012
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3Daniel Nowak, Marion Klaumuenzer, Benjamin Hanfstein, et al.
Nature Genetics|November 5, 2025
Epigenetically driven and early immune evasion in colorectal cancer evolutionEszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Epigenome and early selection determine the tumour-immune evolutionary trajectory of colorectal cancerEszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
British Journal of Haematology|January 24, 2021
High erythroferrone expression in CD71<sup>+</sup> erythroid progenitors predicts superior survival in myelodysplastic syndromesVladimir Riabov, Maximilian Mossner, Alexandra Stöhr, et al.
Cell Stem Cell|April 8, 2014
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unitHind Medyouf, Maximilian Mossner, Johann-Christoph Jann, et al.
Blood|June 9, 2016
Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failureMaximilian Mossner, Johann-Christoph Jann, Janina Wittig, et al.
Nature Cancer|May 14, 2025
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinomaMelissa Barroux, Jacob Househam, Eszter Lakatos, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Annals of Hematology|February 27, 2024
Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic NeoplasmsAlexander Streuer, Johann-Christoph Jann, Tobias Boch, et al.
Oncotarget|November 22, 2017
Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancerElke Burgermeister, Patrick Höde, Johannes Betge, et al.
Journal of Medical Genetics|June 11, 2017
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNAJohann-Christoph Jann, Daniel Nowak, Florian Nolte, et al.
Genes, Chromosomes & Cancer|April 11, 2012
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3Daniel Nowak, Marion Klaumuenzer, Benjamin Hanfstein, et al.
Nature Genetics|November 5, 2025
Epigenetically driven and early immune evasion in colorectal cancer evolutionEszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Epigenome and early selection determine the tumour-immune evolutionary trajectory of colorectal cancerEszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
British Journal of Haematology|January 24, 2021
High erythroferrone expression in CD71<sup>+</sup> erythroid progenitors predicts superior survival in myelodysplastic syndromesVladimir Riabov, Maximilian Mossner, Alexandra Stöhr, et al.
Cell Stem Cell|April 8, 2014
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unitHind Medyouf, Maximilian Mossner, Johann-Christoph Jann, et al.
Blood|June 9, 2016
Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failureMaximilian Mossner, Johann-Christoph Jann, Janina Wittig, et al.
Nature Cancer|May 14, 2025
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinomaMelissa Barroux, Jacob Househam, Eszter Lakatos, et al.
Pageof 4